martes, 8 de abril de 2014

NIH Funding Opportunity Focuses on Diagnostics for Hospital-Based Antibacterial-Resistant Infections

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases
NIAID News Twitter   NIAID Facebook   NIAID News Twitter   LinkedIn Icon
Visit us on the Web
NIH Funding Opportunity Focuses on Diagnostics for Hospital-Based Antibacterial-Resistant Infections
NIAID recently announced a research funding opportunity to develop and/or produce diagnostics to quickly detect the key bacteria responsible for antibacterial-resistant infections in hospital settings. The request for applications (RFA) will support diagnostics research related to one or more of the following types of bacteria: Klebsiella pneumoniaAcinetobacter baumanniiPseudomonas aeruginosaEnterobacter species, and extra-intestinal pathogenic Eschericihia coli. NIAID expects to fund 10-15 awards for a total of up to $12 million in 2015, and the maximum length of each award is 5 years.
NIAID will accept applications through June 19, 2014. View the complete RFA (RFA-AI-14-019).

No hay comentarios:

Publicar un comentario